| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |